by Clinical Neuropsychologist | Monday, February 3, 2025 | Dementia
Abstract INTRODUCTION Identifying the link between early Alzheimer’s disease (AD) pathological changes and neurodegeneration in asymptomatic individuals may lead to the discovery of preventive strategies. We assessed longitudinal brain atrophy and cognitive...
by Clinical Neuropsychologist | Monday, February 3, 2025 | Neuroscience
Nature Neuroscience, Published online: 03 February 2025; doi:10.1038/s41593-025-01870-0Using the AstroLight system, the authors reveal that astrocytic ensembles in the nucleus accumbens regulate cue-motivated reward behavior, demonstrating that selective manipulation...
by Clinical Neuropsychologist | Saturday, February 1, 2025 | Neuro Podcasts
Today we give you our conversation with Dr. Andrew Kiselica about neuropsychological test interpretation. Andrew is a board-certified clinical neuropsychologist and Associate Professor in the Institute of Gerontology at the University of Georgia. He recently first...
by Clinical Neuropsychologist | Thursday, January 30, 2025 | Dementia
Abstract INTRODUCTION The phase 3 trial CLARITY AD found lecanemab slowed cognitive decline by 27%. However, subgroup analyses indicated a significant 31% sex difference in the effect and suggested no or limited effectiveness in females. We used simulations...
by Clinical Neuropsychologist | Thursday, January 30, 2025 | Neuroscience
Nature Neuroscience, Published online: 30 January 2025; doi:10.1038/s41593-025-01879-5Lynn T. Landmesser, professor emerita of the Department of Neurosciences, School of Medicine at Case Western Reserve University, died on 29 November 2024 at the age of 80. In an...
